insights_auto
Outlook: 53.9% bullish·1.7% bearish
Go to analysischevron_right
LLY:NYSE
Eli Lilly And Co
1 362,65 $
arrow_downward
-0,15%(-2,08) 1D
6 қар., 14:39:13 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LLY...
Open
1 350,45 $
High
1 377,28 $
Low
1 333,22 $
Mkt. cap
1,28 трлн
Avg. vol.
2,63 млн
Volume
1,80 млн
Dividend
0,51%
Quarterly dividend
1,73 $
Ex-dividend date
2026 ж. 14 там.
P/E ratio
44,23
52-wk high
1 449,68 $
52-wk low
850,51 $
EPS
30,81 $
Beta
0,40
Shares outstanding
940,74 млн
No. of employees
50 мың
Open
1 350,45 $
High
1 377,28 $
Low
1 333,22 $
Mkt. cap
1,28 трлн
Avg. vol.
2,63 млн
Volume
1,80 млн
Dividend
0,51%
Quarterly dividend
1,73 $
Ex-dividend date
2026 ж. 14 там.
P/E ratio
44,23
52-wk high
1 449,68 $
52-wk low
850,51 $
EPS
30,81 $
Beta
0,40
Shares outstanding
940,74 млн
No. of employees
50 мың
News stories
From web sources and news partners
Investing.com
·
2 сағат бұрын
Hims & Hers stock climbs on direct partnership with Eli Lilly for obesity drugs
Benzinga
·
2 сағат бұрын
Telehealth Giant Hims & Hers Partners with Eli Lilly for Direct Weight Loss Drug Delivery
News Corp
·
3 сағат бұрын
Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.
MarketWatch
·
3 сағат бұрын
Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Co
CEODavid A. Ricks
Employees50 мың
Founded1876
HeadquartersИндианаполис, Индиана, Америка Құрама Штаттары
SectorHealth Care
IndustryPharmaceutical industry
Websitelilly.com